ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set

August 11, 1978

Institute of Medicine Elects 80 New Members

October 24, 2014

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act

September 20, 1974